![]() |
Multi-center ALS Study ... NeuRx® DPS™ Shows ... Survival Post-Implant of 20.9 months
Multi-center ALS Study Using the NeuRx® Diaphragm Pacing System™ (DPS) Shows Safety and Survival Post-Implant of 20.9 Months
http://www.prnewswire.com/news-relea...300133229.html |
NeuRx study expands to 150 patients
U.S. Diaphragm Pacing Study in ALS Continues Enrollment: The Post Approval Study's (PAS) Interim Data Showed Device Safety and Median Survival Post-Implant of 20.9 months
http://goo.gl/ojDItX http://www.prnewswire.com/news-relea...300158826.html |
All times are GMT -5. The time now is 09:02 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.